To understand this, we performed a T cell–mediated tumor cell killing assay using the ST6GalNAc-I–KO or control cells with peripheral blood lymphocytes (PBLs) or activated T cells (Figure 3, A and B). Here, ST6GALNAC1 is linked to neoplasm.